AUSTIN, Texas–(BUSINESS WIRE)–Texas Original Compassionate Cultivation (TXOG), Texas’ leading medical cannabis provider, today released results from its post-traumatic stress disorder (PTSD) focus group detailing the positive effects of medical cannabis use. The focus group consisted of veterans suffering from PTSD who qualify for medical cannabis under the expanded Compassionate Use Program.

Notably, 100% of the focus group participants reported they experienced relief from their symptoms associated with PTSD with TXOG’s product. This response reflects recent peer-reviewed studies from Wayne State University and the Federal University of Paraná that reported lower threat-related amygdala reactivity and suppressed anxiety in PTSD patients using medical cannabis.

“Many veterans in Texas and around the country face a much different enemy when they return home, one who is invisible but no less dangerous,” said Morris Denton, CEO of TXOG. “Medical cannabis plays a critical role in many of those veterans’ lives. TXOG stands committed to being an ally in that fight by doing whatever we can to not only help them find symptom relief, but to continue to drive the expansion of medical cannabis legislation that enhances accessibility for more veterans and other Texans suffering from PTSD.”

Focus group participants sampled TXOG’s gummy, lozenge and tincture products at various dosages based on prescriptions from their physicians. Patients overwhelmingly reported a quick product onset, with 77% and 62% of participants experiencing an onset within 30 minutes for gummies and tinctures, respectively. Eighty-five percent of participants also reported they were mostly or very satisfied with the product’s onset. Notably, more than 60% of participants reported a preference for TXOG’s gummy products, which are available in a 0:1 THC-only formulation as well as a 1:1 THC-to-CBD formulation.

Participants also unanimously reported a reduction in supplemental medication consumption after introducing TXOG’s medical cannabis products. All patients reported some level of reduction, with more than 30% of participants removing additional medications or pharmaceutical products completely from their treatment plans in collaboration with their prescribing physicians.

“I was previously prescribed high doses of clonazepam and was pretty much a zombie throughout my time taking it,” a study participant noted. “Once I found out that PTSD was added as a qualifying condition under the Compassionate Use Program, I met with a doctor and contacted Texas Original. This medicine has absolutely changed my life. Before incorporating medical cannabis into my treatment plan, I was afraid to leave my home. This medicine gives me the confidence to go out in public and interact with people. During and following the study, I even started going fishing and hiking more!”

TXOG’s gummy, tincture and lozenge products are available for statewide delivery at www.texasoriginal.com, at their dispensary in Austin, Texas, and through the company’s convenient pick-up locations in North Austin, Addison, Dallas, Fort Worth, Houston, San Antonio and Wichita Falls. To learn whether you or a loved one qualifies for medical cannabis, visit www.texasoriginal.com/patients.

About Texas Original Compassionate Cultivation

Texas Original Compassionate Cultivation (TXOG) is the leading licensed medical marijuana producer in Texas, working alongside physicians to provide the highest quality cannabis medicine to patients and families seeking relief across the state. As fellow Texans, we are dedicated to representing the integrity of this great state with our commitment to quality, consistency and purity in every product we produce. We remain committed to advancing safe, legal access to this powerful medicine. TXOG is headquartered in Austin, with delivery throughout the entire state. For more information, visit www.texasoriginal.com.